1. Out-of-pocket costs for Rx drugs are expected to increase, but will likely represent a smaller portion of overall Rx spending
Percent of total Rx spending (2000 – 2016), and percent of projected Rx spending (2017 – 2026) by out-of-pocket vs. private insurance and Medicare
While per capita out-of-pocket spending on prescription drugs is expected to grow in coming years, it has fallen as a share of total drug spending and this trend is projected to continue into future years. Medicare is expected to represent a growing share of drug spending over the next decade.
Source: Kaiser Family Foundation analysis of National Health Expenditure (NHE) Historical ( ) and Projected ( ) data from Centers for Medicare and Medicaid Services, Office of the Actuary, National Health Statistics Group (Accessed on May 2, 2018)